Publications by authors named "Calogero Lauricella"

Claim this Profile
B
Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients.
Daniele Lorenzini, Gabriella Gaudioso, Alessandro Scardoni, Lorenzo Blandi, Alessandro Del Gobbo, Calogero Lauricella

Tumori· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Part III - Post-analytical phase.
Simonetta Buglioni, Davide Seminati, Rossella Bruno, Beatrice Casini, Valerio Gristina, Calogero Lauricella

Pathologica· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SMARCB1/INI1-deficient undifferentiated tumour of the thorax: a case report and review of the literature.
Moreno Zagni, Alessandro Marando, Mariachiara Negrelli, Calogero Lauricella, Valentina Motta

Pathologica· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biphenotypic lung carcinoma with coexpression of TTF-1 and ΔNP63/P40 within most of the same individual cells: a further case confirming poor prognosis and a review of literature.
Alessandro Marando, Moreno Zagni, Mariachiara Negrelli, Emanuele Valtorta, Calogero Lauricella

Pathologica· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repotrectinib Overcomes F2004V Resistance Mutation in -Rearranged NSCLC: A Case Report.
Elio Gregory Pizzutilo, Alberto Giuseppe Agostara, Laura Roazzi, Rebecca Romanò, Valentina Motta, Calogero Lauricella

JTO Clin Res Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Case report: mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer.
Gianluca Mauri, Giorgio Patelli, Viviana Gori, Calogero Lauricella, Benedetta Mussolin

Front Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Promyelocytic Leukemia with del(6)(p22) and Atypical bcr2 PML::RARA Fusion Transcript: A Case Report.
Calogero Lauricella, Rosa Greco, Valentina Mancini, Valentina Motta, Anna Ciraolo

Acta Haematol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer.
Gianluca Mauri, Giorgio Patelli, Viviana Gori, Calogero Lauricella, Benedetta Mussolin

Front Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Detection and Quantification of DNA in Paraffinized Samples by Droplet Digital PCR: A Preliminary Study.
Maria Antonello, Rossana Scutari, Calogero Lauricella, Silvia Renica, Valentina Motta

Front Microbiol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of droplet digital polymerase chain reaction for measuring BCR-ABL1 in chronic myeloid leukaemia in an international interlaboratory study.
Stuart Scott, Ashley Cartwright, Sebastian Francis, Liam Whitby, A Pia Sanzone, Calogero Lauricella

Br J Haematol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid Biopsy for Small Cell Lung Cancer either De Novo or Transformed: Systematic Review of Different Applications and Meta-Analysis.
Elio Gregory Pizzutilo, Martino Pedrani, Alessio Amatu, Lorenzo Ruggieri, Calogero Lauricella

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients.
Umberto Malapelle, Francesco Passiglia, Chiara Cremolini, Maria Lucia Reale, Francesco Pepe, Calogero Lauricella

Eur J Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down-regulation.
Valentina Zuco, Sandro Pasquali, Monica Tortoreto, Silvia Brich, Stefano Percio, Calogero Lauricella

J Exp Clin Cancer Res· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent Small-Cell Transformation and Emergence of -C797S and T790M Mutations Under Sequential Treatment With EGFR Inhibitors in Lung Adenocarcinoma.
Elio G Pizzutilo, Calogero Lauricella, Giulio Cerea, Laura G Giannetta, Gianluca Tomasello

JCO Precis Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRKA expression and gene copy number across solid tumours.
Gianluca Mauri, Emanuele Valtorta, Giulio Cerea, Alessio Amatu, Michele Schirru, Calogero Lauricella

J Clin Pathol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pooled Analysis of Clinical Outcome of Patients with Chemorefractory Metastatic Colorectal Cancer Treated within Phase I/II Clinical Studies Based on Individual Biomarkers of Susceptibility: A Single-Institution Experience.
Andrea Sartore-Bianchi, Alessio Amatu, Erica Bonazzina, Stefano Stabile, Laura Giannetta, Calogero Lauricella

Target Oncol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer.
Jérôme Solassol, Julie Vendrell, Bruno Märkl, Christian Haas, Beatriz Bellosillo, Calogero Lauricella

PLoS One· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal evolution and - coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer.
Andrea Sartore-Bianchi, Emanuele Valtorta, Alessio Amatu, Silvio Veronese, Calogero Lauricella

ESMO Open· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial.
Andrea Sartore-Bianchi, Livio Trusolino, Cosimo Martino, Katia Bencardino, Sara Lonardi, Calogero Lauricella

Lancet Oncol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer.
Alessio Amatu, Alessio Somaschini, Giulio Cerea, Roberta Bosotti, Emanuele Valtorta, Calogero Lauricella

Br J Cancer· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of a HER2 scoring system for colorectal cancer: results from a validation study.
Emanuele Valtorta, Cosimo Martino, Andrea Sartore-Bianchi, Frédérique Penaullt-Llorca, Giuseppe Viale, Calogero Lauricella

Mod Pathol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapy.
Mirko Marabese, Monica Ganzinelli, Marina C Garassino, Frances A Shepherd, Sheila Piva, Calogero Lauricella

Oncotarget· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enteric-type adenocarcinoma of the lung harbouring a novel KRAS Q22K mutation with concomitant KRAS polysomy: a case report.
Giulio Metro, Emanuele Valtorta, Annamaria Siggillino, Calogero Lauricella, Matteo Cenci

Ecancermedicalscience· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients.
Giulia Siravegna, Benedetta Mussolin, Michela Buscarino, Giorgio Corti, Andrea Cassingena, Calogero Lauricella

Nat Med· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients.
Giulia Siravegna, Benedetta Mussolin, Michela Buscarino, Giorgio Corti, Andrea Cassingena, Calogero Lauricella

Nat Med· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis